13. Earnings (Loss) Per Common Share (EPS)

The computations of basic and diluted earnings (loss) per share were as follows for the periods presented below:

For the three month period ended June 30, 2025, the Company had unexercised stock options of 288,570, RSAs of 125,087 and warrants to purchase 150,000 shares of common stock, outstanding, that were anti-dilutive. For the three month period ended June 30, 2024 , the Company had unexercised stock options of 288,570, RSAs of 173,524 and warrants to purchase 150,000 shares of common stock, outstanding, that were anti-dilutive.

For the six month period ended June 30, 2025, the Company had unexercised stock options of 288,570, RSAs of 125,087 and warrants to purchase 150,000 shares of common stock, outstanding, that were anti-dilutive. For the six month period ended June 30, 2024 , the Company had unexercised stock options of 288,570, RSAs of 173,524 and warrants to purchase 150,000 shares of common stock, outstanding, that were anti-dilutive.